Johnson & Johnson (JNJ) Cash from Investing Activities (2009 - 2026)
Johnson & Johnson recorded quarterly Cash from Investing Activities of -$1.0 billion in Q1 2026, up 76.81% quarter-over-quarter from -$4.5 billion in Q4 2025, and down 250.17% year-over-year from $692.6 million in Q1 2025.
Johnson & Johnson's Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$1.0 billion for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 250.17% year-over-year to -$1.0 billion; the TTM figure through Mar 2026 stood at -$24.3 billion (down 32.0% YoY), while the FY2025 annual figure was -$23.6 billion, down 26.82% from the prior year.
- Cash from Investing Activities came in at -$1.0 billion for Q1 2026 at Johnson & Johnson, up from -$4.5 billion in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $3.3 billion in Q2 2023 to a low of -$18.3 billion in Q2 2025.
- A 5-year average of -$3.7 billion and a median of -$1.3 billion in 2024 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities tumbled 1864.32% in 2022 and soared 191.22% in 2023, its largest moves.
- Johnson & Johnson's Cash from Investing Activities stood at -$3.6 billion in 2022, then soared by 66.92% to -$1.2 billion in 2023, then retreated by 9.82% to -$1.3 billion in 2024, then plunged by 239.77% to -$4.5 billion in 2025, then jumped by 76.81% to -$1.0 billion in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$1.0 billion, -$4.5 billion, and -$542.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -3.92 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -1.04 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -574.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -10.21 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -716.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 1.77 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 785.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -131.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -1.04 Bn |
| Mar 29, 2026 | -1.04 Bn |
| Dec 28, 2025 | -4.49 Bn |
| Dec 28, 2025 | -4.49 Bn |
| Sep 28, 2025 | -542.00 Mn |
| Sep 28, 2025 | -542.00 Mn |
| Jun 29, 2025 | -18.26 Bn |
| Jun 29, 2025 | -18.26 Bn |
| Mar 30, 2025 | -297.00 Mn |
| Mar 30, 2025 | -297.00 Mn |
| Dec 29, 2024 | -1.32 Bn |
| Dec 29, 2024 | -1.32 Bn |
| Sep 29, 2024 | -3.13 Bn |
| Sep 29, 2024 | -3.13 Bn |
| Jun 30, 2024 | -13.69 Bn |
| Jun 30, 2024 | -13.69 Bn |
| Mar 31, 2024 | -464.00 Mn |
| Mar 31, 2024 | -464.00 Mn |
| Dec 31, 2023 | -1.20 Bn |
| Dec 31, 2023 | -1.20 Bn |
| Oct 1, 2023 | 2.54 Bn |
| Oct 1, 2023 | 2.54 Bn |
| Jul 2, 2023 | -3.78 Bn |
| Jul 2, 2023 | -3.78 Bn |
| Apr 2, 2023 | 3.32 Bn |
| Apr 2, 2023 | 3.32 Bn |
| Jan 1, 2023 | -9.05 Bn |
| Jan 1, 2023 | -9.05 Bn |
| Apr 3, 2022 | -3.63 Bn |
| Apr 3, 2022 | -3.63 Bn |
| Oct 3, 2021 | -2.72 Bn |
| Oct 3, 2021 | -2.72 Bn |
| Jul 4, 2021 | -419.00 Mn |
| Jul 4, 2021 | -419.00 Mn |
| Apr 4, 2021 | -185.00 Mn |
| Apr 4, 2021 | -185.00 Mn |
| Jan 3, 2021 | -7.90 Bn |
| Jan 3, 2021 | -7.90 Bn |
| Sep 27, 2020 | -4.82 Bn |
| Sep 27, 2020 | -4.82 Bn |
| Jun 28, 2020 | -7.52 Bn |
| Jun 28, 2020 | -7.52 Bn |
| Mar 29, 2020 | -581.00 Mn |
| Mar 29, 2020 | -581.00 Mn |
| Dec 29, 2019 | -1.34 Bn |
| Dec 29, 2019 | -1.34 Bn |
| Sep 29, 2019 | -1.65 Bn |
| Sep 29, 2019 | -1.65 Bn |
| Jun 30, 2019 | -1.79 Bn |
| Jun 30, 2019 | -1.79 Bn |
| Mar 31, 2019 | -1.42 Bn |
| Mar 31, 2019 | -1.42 Bn |
| Dec 30, 2018 | 2.23 Bn |
| Dec 30, 2018 | 2.23 Bn |
| Sep 30, 2018 | -4.27 Bn |
| Sep 30, 2018 | -4.27 Bn |
| Jul 1, 2018 | -201.00 Mn |
| Jul 1, 2018 | -201.00 Mn |
| Apr 1, 2018 | -925.00 Mn |
| Apr 1, 2018 | -925.00 Mn |
| Dec 31, 2017 | -505.00 Mn |
| Dec 31, 2017 | -505.00 Mn |
| Oct 1, 2017 | -1.18 Bn |
| Oct 1, 2017 | -1.18 Bn |
| Jul 2, 2017 | -12.25 Bn |
| Jul 2, 2017 | -12.25 Bn |
| Apr 2, 2017 | -936.00 Mn |
| Apr 2, 2017 | -936.00 Mn |
| Jan 1, 2017 | 1.58 Bn |
| Jan 1, 2017 | 1.58 Bn |
| Apr 3, 2016 | -1.54 Bn |
| Apr 3, 2016 | -1.54 Bn |
| Sep 27, 2015 | -1.00 Bn |
| Sep 27, 2015 | -1.00 Bn |
| Jun 28, 2015 | -3.55 Bn |
| Jun 28, 2015 | -3.55 Bn |
| Mar 29, 2015 | -1.79 Bn |
| Mar 29, 2015 | -1.79 Bn |
| Dec 28, 2014 | -2.92 Bn |
| Dec 28, 2014 | -2.92 Bn |
| Sep 28, 2014 | 735.00 Mn |
| Sep 28, 2014 | 735.00 Mn |
| Jun 29, 2014 | -8.09 Bn |
| Jun 29, 2014 | -8.09 Bn |
| Mar 30, 2014 | -2.03 Bn |
| Mar 30, 2014 | -2.03 Bn |
| Dec 29, 2013 | -1.58 Bn |
| Dec 29, 2013 | -1.58 Bn |
| Sep 29, 2013 | -1.55 Bn |
| Sep 29, 2013 | -1.55 Bn |
| Jun 30, 2013 | -569.00 Mn |
| Jun 30, 2013 | -569.00 Mn |
| Mar 31, 2013 | -1.40 Bn |
| Mar 31, 2013 | -1.40 Bn |
| Dec 30, 2012 | -2.50 Bn |
| Dec 30, 2012 | -2.50 Bn |
| Sep 30, 2012 | -1.94 Bn |
| Sep 30, 2012 | -1.94 Bn |
| Jul 1, 2012 | -4.13 Bn |
| Jul 1, 2012 | -4.13 Bn |
| Apr 1, 2012 | 4.06 Bn |
| Apr 1, 2012 | 4.06 Bn |
| Jan 1, 2012 | 1.84 Bn |
| Jan 1, 2012 | 1.84 Bn |
| Apr 3, 2011 | 1.44 Bn |
| Apr 3, 2011 | 1.44 Bn |
| Oct 3, 2010 | -1.88 Bn |
| Oct 3, 2010 | -1.88 Bn |
| Jul 4, 2010 | -2.69 Bn |
| Jul 4, 2010 | -2.69 Bn |
| Apr 4, 2010 | -1.88 Bn |
| Apr 4, 2010 | -1.88 Bn |
| Jan 3, 2010 | -2.36 Bn |
| Jan 3, 2010 | -2.36 Bn |
| Sep 27, 2009 | -1.86 Bn |
| Sep 27, 2009 | -1.86 Bn |
| Jun 28, 2009 | -2.30 Bn |
| Jun 28, 2009 | -2.30 Bn |
| Mar 29, 2009 | -1.08 Bn |
| Mar 29, 2009 | -1.08 Bn |